Membrane repair deficit in facioscapulohumeral muscular dystrophy
International Journal of Molecular Sciences
Antioxidant; Antisense oligonucleotide; DUX4; FSHD; Gapmer; Membrane; MOE; Muscle; Myoblast; Myofiber; Repair
Deficits in plasma membrane repair have been identified in dysferlinopathy and Duchenne Muscular Dystrophy, and contribute to progressive myopathy. Although Facioscapulohumeral Muscular Dystrophy (FSHD) shares clinicopathological features with these muscular dystrophies, it is unknown if FSHD is characterized by plasma membrane repair deficits. Therefore, we exposed immortalized human FSHD myoblasts, immortalized myoblasts from unaffected siblings, and myofibers from a murine model of FSHD (FLExDUX4) to focal, pulsed laser ablation of the sarcolemma. Repair kinetics and success were determined from the accumulation of intracellular FM1-43 dye post-injury. We subsequently treated FSHD myoblasts with a DUX4-targeting antisense oligonucleotide (AON) to reduce DUX4 expression, and with the antioxidant Trolox to determine the role of DUX4 expression and oxidative stress in membrane repair. Compared to unaffected myoblasts, FSHD myoblasts demonstrate poor repair and a greater percentage of cells that failed to repair, which was mitigated by AON and Trolox treatments. Similar repair deficits were identified in FLExDUX4 myofibers. This is the first study to identify plasma membrane repair deficits in myoblasts from individuals with FSHD, and in myofibers from a murine model of FSHD. Our results suggest that DUX4 expression and oxidative stress may be important targets for future membrane-repair therapies.
Bittel, A., Sreetama, S., Bittel, D., Horn, A., Novak, J., Yokota, T., Zhang, A., Maruyama, R., Lim, K., Jaiswal, J., & Chen, Y. (2020). Membrane repair deficit in facioscapulohumeral muscular dystrophy. International Journal of Molecular Sciences, 21 (15). http://dx.doi.org/10.3390/ijms21155575